Life Sciences MVP: O'Melveny's Paul Scrivano

Law360, New York (December 4, 2012, 5:20 PM EST) -- O'Melveny & Myers LLP partner Paul Scrivano has a broad mergers and acquisitions practice, but it is his work on cross-border deals involving the cutting edge of the biotech industry and an innovative investment in a Georgia firm that earned him a spot on Law360's list of Life Sciences MVPs.

Stretching back to October 2011, Scrivano has been involved in a string of major deals in the life sciences field, including representing Chinese orthopedic implant maker China Kanghui Holdings as it negotiated an $816 million buyout...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.